Dr. Christopher David Flanagan, MD

Dr. Flanagan practices at Lakeland Regional Health Systems, Inc. in Lakeland, Florida.

Dr. Flanagan's NPI, 1841686771, was assigned on April 7, 2015. Dr. Flanagan graduated from Pritzker School of Medicine in 2015. Dr. Flanagan holds Florida license ME147624.

Dr. Flanagan's primary practice is Lakeland Regional Health Systems, Inc., at 3030 Harden Blvd, Lakeland, FL 33803 in Polk County. The practice phone is (863) 687-7251.

Dr. Flanagan's primary practice is Lakeland Regional Health Systems, Inc. in Lakeland, Florida. Dr. Flanagan is also affiliated with Lakeland Regional Health Medical Center. The medical group on file is Lakeland Regional Health. Dmand AI also links Dr. Flanagan to 1 more hospital, 3 home health agencies, 2 group practices and clinics, 2 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Flanagan practices, 8 sites in all. Vendor and product names are available with a free account.

Orthopaedic trauma is Dr. Flanagan's primary specialty in the NPI Registry, under taxonomy code 207XX0801X. Dr. Flanagan is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Flanagan's licenses on file in 2 states: Florida and Ohio.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, bursitis, carpal tunnel syndrome, hip replacement, joint pain, knee fracture and dislocation and knee injury among the conditions Dr. Flanagan treats.

CMS data shows 2,909 Medicare services from Dr. Flanagan across 11 procedure codes in 2024, for 258 Medicare patients. Medicare paid $63,781 for them. Every service was in an office.

CMS counts 258 Medicare patients who saw Dr. Flanagan in 2024. The largest group is 75 to 84, with 112 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Flanagan's median patient age at 67, with 55% women.

In 2024, Dr. Flanagan wrote 419 Medicare Part D claims for 172 patients. 100% of them were for generic drugs. CMS names the drug for 345 of them, across 7 drugs with 11 or more claims each, at $1,876 in total drug cost. In 2023, CMS named 349 claims across 7 drugs.

Dr. Flanagan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Knee replacement: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 30 papers to Dr. Flanagan, published from 2013 to 2025. 2020 was the busiest year, with 4. The most frequent topics are Fractures, Bone, Orthopedics and Fracture Fixation, Internal. Dr. Flanagan has published most often in J Orthop Trauma. Dr. Flanagan's most frequent co-authors are Heather A. Vallier, MD, Hassan Riaz Mir, MD and Noah Michael Joseph.

CMS Open Payments shows 44 general payments to Dr. Flanagan from 17 drug and device companies from 2019 to 2025. Education make up the largest share, 64% of the total. Smith & Nephew, Inc. paid the most, $9,917.

Dr. Flanagan graduated from Pritzker School of Medicine in 2015.

Dr. Flanagan is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.